Talphera, Inc. ( (TLPH) ) has released its Q3 earnings. Here is a breakdown of the information Talphera, Inc. presented to its investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for medically supervised settings, with a notable emphasis on its lead product candidate, Niyad, which is under investigation as an anticoagulant for extracorporeal circuits.